Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news
    • Coronavirus Outbreak:...

    Coronavirus Outbreak: OPPI assures continuity of supply of medicines

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-03-17T09:00:00+05:30  |  Updated On 17 March 2020 9:00 AM IST
    Coronavirus Outbreak: OPPI assures continuity of supply of medicines

    OPPI and its member companies reassure the availability of adequate supplies of medicines for those in need of them

    Mumbai: In line with its patient-first approach, Organisation of Pharmaceutical Producers of India (OPPI), which represents the research-based pharmaceutical companies has reiterated the support and commitment of its members towards working with the Government of India in addressing the COVID-19 situation by ensuring continuity of supply of medicines.

    "OPPI and its member companies reassure the availability of adequate supplies of medicines for those in need of them" OPPI stated

    OPPI confirms that currently, its member companies have adequate inventory in India and efforts are being made to step up further production.

    "OPPI members are committed to working on measures to ensure that there are no shortages and that there is continuity in the pharmaceutical supply chain through focused engagement with all critical stakeholders across the supply chain" OPPI further stated

    "In response to public health challenges driven by scientific research, as a science-driven industry OPPI aims to address some of the world's biggest health care challenges, the research-based pharmaceutical industry clearly has a role to play in developing new and improved medicines and vaccines to help respond to this epidemic. From the outset of the epidemic, global research-based pharmaceutical companies have reviewed their drug and vaccine portfolios to see if there is any research that could be of help" release stated

    This analysis involved scientists assessing the companies' libraries for potentially useful assets that could help with the development of new or repurposed treatments or vaccines to fight against the novel coronavirus: Relevant assets include diagnostics and biomarkers, approved therapies or compounds in development which could be repurposed for use in treating patients with the coronavirus. In addition, these companies are undertaking to identify any ACE inhibitors, protease inhibitors or immunotherapies that could be relevant in the context of the novel coronavirus.

    Read also: OPPI launches campaign calling for ideas to improve healthcare

    "In line with the advisories issued by the Government and Ministry of Health & Family Welfare on COVID-19, OPPI members are tracking the updates and implementing them on a regular basis. In view of addressing the safety, well-being and good health of employees, partners and other stakeholders, members are committed to following the general precautionary measures that include the universal or standard precautions of general hygiene; maintaining a social distancing of 2 meters or more and avoiding mass gatherings. Members have postponed internal and external meetings, events & gatherings, and travels until further notice" OPPI further added

    OPPI members remain committed and supportive towards working with Government, medical institutions and other stakeholders, in delivering quality patient care during these challenging times.

    Read also: A Vaidheesh re-elected President of OPPI for the third consecutive year

    oppiorganisation-of-pharmaceutical-producers-of-indiacoronaviruscovid-19

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok